| Home page | News | About us | Investment | Contact us | 
Position: China Medical City >> News >> Major CMC News >> The text
NAVIGATION
NEWS IN PICTURES

A Project of the Pro…

The Eighth China (Ta…

30 Projects Settled …

The 8th China (Taizh…
[Article with image]Ascentage Pharma Wins the Team Award at the First Innovation Evaluation Activity           ★★★
Ascentage Pharma Wins the Team Award at the First Innovation Evaluation Activity

Author:cmc Article source:cmc Click the number:340 Update time:2017-6-8 9:22:17

 Recently, Ascentage Pharma, a company settled in CMC, brought good news! The company's Internationally Original Action Mechanism-Based Anti-tumor Drug R&D Team led by Dr. Yang Dajun stood out at the first Innovation Evaluation Activity of Jiangsu Province and won the Team Award. A total of 10 teams across the province won this award and only one was from Taizhou. Ascentage Pharma was also the only bio-pharmaceutical company across the province to win this award.

Ascentage Pharma's Internationally Original Action Mechanism-Based Anti-tumor Drug R&D Team was set up in May 2009 with the company's Chairman and CEO Dr. Yang Dajun as the leader and now has 120 members. The team carries out design, research and development of internationally original action mechanism-based anti-tumor drugs with the support of Jiangsu Key Laboratory of Drug Design and Optimization and the "Corporate Original Drug Incubation Base" of the National Major Scientific and Technological Special Project for Significant New Drugs Development. The team has completed a strategic product layout in three therapeutic fields: tumor, hepatitis B and aging-related diseases. The team is internationally among the first to enter the R&D field of new target small molecule inhibitors via regulation of apoptosis and autophagy. The team holds an international leading position in the protein-protein interaction drug design field in terms of technology and has more than 100 domestic and foreign invention patents. Three members of the team have been enlisted in the Recruitment Program of Global Experts by the Organization Department of the CPC Central Committee. Dr. Yang Dajun and Dr. Guoming were consecutively awarded the China Overseas Chinese Contribution Award (Innovative Talent category) by the Overseas Chinese Affairs Office of the State Council. In 2011, the team was selected as the Scientific and Technological Innovation Team of Jiangsu Province and the Key Overseas Chinese Entrepreneurial Team of the Overseas Chinese Affairs Office of the State Council.

NewsInputer:CMC    Editor:CMC 
  • Back ArticleNews:

  • Next ArticleNews:
  • 【Typeface:Small Big】【Comment】【Add favorite】【Mail this page】【Print】【Close
      The netizen comments:(Show only the latest 10. Review the content of view, has nothing to do with the stand!)

    | Set home | Add to Favorites | Contact the webmaster | About us |
    Copyright © 2014 Medmax.cn Inc. All rights reserved. Medmax.cn
    The competent units:Taizhou National Medical High-tech Development Zone
    Copyright: Taizhou pharmaceutical hi tech Industrial Park Management Committee
    Tel:0523-86200007;+86-15852977958;0523-86200142;+86-18262307755
    苏ICP备14026810号-1 苏B2-20070164
    回到最上头